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Catecholamines and phosphate excretion by the remnant kidney. The
remnant kidney (RK) exhibits an enhanced fractional excretion of
phosphate (FE) even in the absence of parathyroid hormone (PTH).
Thus, factors other than PTH contribute to this adaptive phosphaturia.
Dopamine (DA) infusion is phosphaturic, whereas stimulation of
adrenoreceptors is antiphosphaturic. Therefore, the hypothesis that
alterations in catecholamines by the RK may be associated with the
phosphaturia exhibited by this model was tested. Male Sprague-Dawley
rats were subjected to right nephrectomy and surgical ablation of the
left renal poles. Four weeks later rats with a RK (N = 10) and control
rats with intact kidneys (N = 9) were anesthetized and thyroparathy-
roidectomized (TPTX). Two hours after TPTX, urine samples were
collected for measurements of urinary free DA excretion. Subse-
quently, 3% inulin in saline was infused for one hour and a 30 minute
clearance was taken. The kidneys were then removed and frozen for
determination of tissue norepinephrine (NE) and DA concentrations.
Glomerular filtration rate was significantly lower in rats with a RK than
in controls (0.57 0.07 vs. 0.83 0.08 ml/min/g kidney wt), whereas
fractional excretion of phosphate (FE) was significantly higher (29.4
4.7 vs. 8.3 3.4%). Tissue NE concentration was significantly lower in
the RK than in the control intact kidney (85,10 4.95 vs. 129.60 7.20
ng/g), whereas urinary DA excretion per nephron was significantly
higher in the RK (0.12 0.02 vs. 0.04 0.006 pg/mm). Infusion of the
specific DA-l receptor antagonist (SCH 23390) in rats with a RK
significantly decreased the FE when compared to the saline infused
control group (—5.2 4.3 vs. +9.5 5.2%), however, urinary c-AMP
excretions were not different. We conclude that decreased renal sym-
pathetic nerve tone, unchanged tissue DA levels, and an increased DA
synthesis per residual nephron are associated with the enhanced FE1
exhibited by the RK.
Animal models of reduced renal mass undergo a series of
adaptive mechanisms to maintain homeostasis. This renal ad-
aptation is characterized by morphological changes as evi-
denced by hypertrophy of glomeruli and nephron subsegments,
hemodynamic changes shown by increases in single nephron
glomerular filtration rate, and alterations in the tubular handling
of solutes [1—5]. Compensatory changes in the tubular handling
of phosphate include an increased fractional excretion of phos-
phate even in the absence of parathyroid glands, a hyperrespon-
siveness to exogenous parathyroid hormone (PTH), and a delay
in the adaptation to a low phosphate diet [6, 7]. It is well
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recognized that mechanisms in addition to those mediated by
PTH contribute to the enhanced fractional excretion of phos-
phate exhibited by the remnant kidney (RK) model of early
chronic renal insufficiency. These mechanisms, however, are
not well defined [8, 9].
The sympathetic innervation of the renal tubules is well
documented in the rat [10, 11]. a- and -adrenoreceptors have
been characterized in the rat proximal tubules [12, 131. The
renal nerves and catecholamines have been demonstrated to
play a role in the renal handling of phosphate. Renal denerva-
tion is phosphaturic [14]. Conversely, stimulation of adreno-
receptors is antiphosphaturic [15—17].
Extraneuronal dopamine (DA) is synthesized by kidney prox-
imal tubular cells [18]. Aromatic 1-amino acid decarboxylase,
the enzyme responsible for the conversion of L-DOPA to DA,
has been well characterized in the kidney of the rat, and its
activity in the nephron is confined to the proximal tubule and
pars recta subsegments of the nephron [19]. DA receptors have
been documented in the proximal tubule, and a paracrine role
for intrarenally synthesized DA in the renal handling of solutes
has been suggested [20, 21]. In addition, DA has been shown to
be phosphaturic in the dog and the rat [22, 23], and urinary DA
excretion directly correlates with changes in dietary phosphate
intake [24].
The objective of the present study was to determine factors
other than PTH that may contribute to the enhanced fractional
excretion of phosphate exhibited by the RK during early stages
of chronic renal insufficiency. It is proposed that alterations in
the RK catecholamines might be associated with the adaptive
phosphaturia exhibited by this model.
Methods
Remnant kidney (RK) model of early chronic renal
insufficiency
Male rats weighing 200 to 250 g, from Harlan-Sprague-
Dawley (Indianapolis, Indiana, USA), were used in this study.
The rats were anesthetized with an intramuscular injection (0.1
mLIlOO g body wt) of equal volumes of a solution of Xylazine
(Lloyd Laboratories, 20 mg/ml), and Ketamine hydrochloride
(Ketalar, 100 mg/mI, Parke-Davis). Under aseptic and antisep-
tic conditions, a right nephrectomy and surgical ablation of the
left renal poles were performed. The poles of the left kidney
were carefully freed. The adrenal gland was left intact, and the
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renal pedicle avoided. A loop was made using a 4-0 chromic gut
suture (Ethicon, Inc., Somerville, New Jersey, USA) and
positioned around the renal pole to be removed. The ioop was
tightened, and at the same time that it sectioned the renal pole
in a well defined plane, it provided hemostasis so that bleeding
was minimized. The right kidney was removed by ligation of the
renal pedicle with 4-0 silk (Ethicon) and ligation of the right
ureter with 4-0 chromic gut. The right kidney and left renal
poles were weighed. The abdominal wall was closed in two
planes with 4-0 silk. The skin was sutured with 4-0 chromic gut.
After total recovery from the surgery (4 to 6 hours), the rats
were placed in the animal facility and allowed free access to
food and water the same night. Survival rate in this group of rats
was 100%. Rats were monitored daily for four weeks. Another
group of rats which served as controls underwent sham surgery
under similar conditions, however, their kidneys remained
intact.
The amount of renal mass removed (in grams) was calculated
by adding the weight of the right kidney and the weight of the
left renal poles removed. The percentage of residual renal mass
was then calculated assuming that the right and left kidney were
the same weight.
Acute clearance experiments
Measurements of urinary dopamine (DA) excretion and renal
tissue norepinephrine (NE) and dopamine (DA) concentrations.
Four weeks after the surgical procedure, rats with a remnant
kidney (N 10) and sham controls (N = 9) were anesthetized
by a 100 mg/kg body wt i.p. injection of 5-sec-butyl-ethyl-2-
thyobarbituric acid (mactin; BYK Golden, Konztanz, Germany)
and placed on a heated table to maintain body temperature
between 36° and 38°C. Rats were acutely thyroparathyroidecto-
mized (TPTX) by heat cautery and a tracheostomy was per-
formed. Polyethylene catheters (PE-50) were placed in the left
jugular vein for infusions and in the left carotid artery for
monitoring mean arterial pressure and collection of blood
samples. A PE-90 catheter was placed in the bladder for
collection of urine samples.
An intravenous infusion of saline (0.9% NaCL) at a rate of 1
ml/100 g body wt was initiated, and a one-hour equilibration
period was allowed after completion of surgery. Two hours
after TPTX urine samples of 1 ml were collected in a container
in ice with 0.15 cc of 33% acetic acid to prevent catecholamine
degradation. Once the urine collection was completed, an
intravenous infusion of 3% inulin in saline (0.9% NaC1), at a rate
of I ml/l00 g body wt, replaced the previous saline infusion and
was continued until the end of the experiment. A one-hour
equilibration period was allowed for the inulin infusion and then
a 30-minute clearance period was taken. At the end of these
collections the remnant kidney and the left intact kidney of the
sham control rats were removed and immediately frozen in dry
ice for determination of tissue NE and DA concentrations.
Effect of DA-1 receptor blockade on the enhanced FE
exhibited by the RK (N = 6). Additional clearance experiments
were performed in rats with a RK. The same experimental
design as for the initial groups was followed except that after
the control clearance was taken, the specific DA-l receptor
antagonist (SCH-23390, 25 pg/kg/min, N = 6) or vehicle (NaCI
0.9%, N 11) was infused for 30 minutes, and an experimental
30 minute clearance was taken.
Urinary cyclic AMP were measured in these experiments
using a radioimmunoassay kit (Biomedical Technologies Inc.,
Stoughton, Massachusetts, USA). Inulin concentrations in
plasma and urine were measured by the anthrone method [25].
Sodium and potassium concentrations in plasma and urine were
measured using ion selective electrodes (Beckman E2 A Ana-
lyzer, Beckman Instruments, Fullerton, California, USA).
Phosphate concentrations in plasma and urine were determined
by the method of Chen, Toribara and Warnner [26]. GFR was
calculated based on the clearance of inulin.
For measurements of urinary free DA, which is a well-
established index of intrarenal DA synthesis [27, 28], the
samples were purified by a modification of the method of
Sharpless et a! [29]. Quantification of urinary DA was then
determined by HPLC with electrochemical detection [30].
Absolute urinary DA excretions were calculated based on the
urinary DA concentrations and urinary flow rate. Because the
hypertrophy that occurs in the RK is due to increases in
nephron size rather than in number [1, 21, the percentage of
residual nephrons for rats with a RK was calculated based on
nephron counts reported by Kaufman et al [311. These authors
studied an identical ablative RK model in Sprague-Dawley rats
with 28% residual renal mass which was followed for four
weeks. They found 10,650 1,982 nephrons in the RK, as
compared with 75,076 2,187 for the intact kidneys. Based on
these findings, urinary DA excretion per nephron was calcu-
lated in both groups of rats in the present study.
For measurements of renal tissue DA and NE concentra-
tions, the latter was considered an established index of the
sympathetic innervation of an organ [32]; the kidneys were
pulverized and homogenized. Kidney homogenates were puri-
fied by a modification of the method of Sharpless et al [29].
Tissue DA and NE concentrations were determined by HPLC
with electrochemical detection and expressed in ng/g of renal
tissue processed. Recoveries of added standards in all of the
extractions averaged 80 to 95%.
All values are reported as means SEM. Comparisons were
made using Student's unpaired t-test. A P < 0.05 was accepted
as a statistically significant difference.
Results
The remnant kidney (RK) model of early chronic renal
insufficiency was characterized (Table 1). No significant differ-
ences in body weight were found between rats with RK and
sham control rats at the time of the first surgery, nor four weeks
later when the acute experiments were conducted. The mean
weight of the right kidney and of the left kidney poles removed
during the first surgery are shown in the Appendix. From the
total renal mass removed, and assuming that the weights of the
right and the left kidneys of the rats were the same, the mean
percentage of residual renal mass for rats with a RK was
calculated to be 37.7 0.8%. The assumption that the right and
left kidneys weights are similar has been previously validated,
and a 3.6% difference (NS) was observed between the left
kidney of a group of uninephrectomized rats and the right
kidney of another group of rats subjected to right nephrectomy
and left renal polectomy [311. The mean weight of the remnant
kidney taken at the end of the acute experiments was signifi-
cantly higher than the weight of the left intact kidney removed
from the sham control rats (1.72 0.04 vs. 1.20 0.02 g).
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Table 1. Renal hemodynamic parameters in rats with a remnant kidney (RK) and in sham control rats with intact kidneys
GFR mi/minig
kidney wt P,1 miii
FE1,
%
FENa
V pi/min MAP mm Hg
RK(N= 10) 0.57 4.2 29.4±4.7a 2.7 45±8 130±3
Sham (N = 9) 0.83 0.08 4.0 0.3 8.3 3.4 1.7 0.4 49 14 134 4
Data are presented as the mean SEM. Abbreviations are: GFR, glomerular filtration rate; P, plasma phosphate concentrations;
fractional excretion of phosphate; FENa, fractional excretion of sodium; V, urinary flow rate; MAP, mean arterial pressure.
a Significantly different, rats with an RK vs. Sham control rats, unpaired t-test, P < 0.05.
Table 2. Effect of infusion of the specific DA1-antagonist SCH 23390 on phosphate handling by the remnant kidney
GFR mi/mm Ig kidney wt P1,1 m FE %
C EC EC E
Time control(N = 11)
SCH 23390(N = 6)
0.64 0.05
0.78 0.08
0.65 0.06
0.79 0.09
3.5
3.5
0.11
0.13
3.3
3.5
0.13
0.2
26.4 5.8
30.4 3.9
36.0 6.5
25.2 2.8
Data are presented as mean SEM. Abbreviations are the same as Table 1. The FE1,1 were significantly different, see Results section.
Clearance experiments were conducted four weeks after
either reduction in renal mass or sham surgery. Glomerular
filtration rate was significantly lower in rats with RK when
compared to the sham controls (0.57 0.07 vs. 0.83 0.08
mllmin/g kidney wt).
Plasma phosphate concentrations were not different between
the two groups of rats (4.23 0.28 m for rats with RK, vs.
4.07 0.27 m for sham control rats). Fractional excretion of
phosphate (FE1) was significantly higher in rats with RK when
compared to sham control rats (FEP, 29.4 4.7 vs. 8.3 3.4%,
Table 1). No significant differences were found in urinary flow
rate, fractional excretion of sodium, or in MAP between rats
with RK and SHAM controls.
Tissue NE concentration was significantly lower in the RK
than in the SHAM control intact kidney (85.12 4.95 vs. 129.60
7.23 nglg of tissue, P < 0.05.), whereas no significant
difference was observed in tissue DA concentrations (8.83
1.33 in the RK vs. 11.43 1.52 nglg of tissue in the intact
control kidney, Fig. 1).
Absolute urinary DA excretion was not significantly different
between sham control rats (2.75 0.48 nglmin) and rats with
RK (1.68 0.24 nglmin, Fig. 2). However, rats with RK have
a significantly reduced number of nephrons compared to sham
control rats with intact kidneys. Kaufman et al studied Sprague-
Dawley rats with RK four weeks after reduction of 72% of the
total renal mass. They counted 10,650 1,982 nephrons in the
RK, which was 14.2% of the total nephron population of 75,076
2,187 nephrons [31]. Thus, a reduced number of nephrons
was clearly observed in the RK, even in the presence of
compensatory increases in mass. The calculated percentage of
residual nephrons for rats with RK in the present study was
18.7%, and the calculated residual nephron population was
14,073. Urinary DA excretion expressed per residual nephrons
in the RK kidney was significantly higher than urinary DA
excreted by 18.7% of the nephrons in sham control rats (1.68
0.24 vs. 0.51 0.08 ng/min, P < 0.05). Further, urinary DA
excretion expressed per nephron was significantly higher in rats
with RK (0.12 0.02 pg/mm) than in sham control rats with
intact kidneys (0.04 0.006 pg/mm, P < 0.05, Fig. 2).
The clearance data for the rats with remnant kidneys in the
presence and absence of the infusion of the specific DA- 1
receptor antagonist (SCH 23390) is summarized in Table 2. The
GFR and plasma phosphate levels were stable in both groups of
rats. In the saline infused time control group, the FE1 was 26.4
5.8% in control collections and 36.0 6.5% during the
experimental period (9.5 5.2%). In the group infused with
SCH 23390, control FE1 was 30.4 3.9 and 25.2 2.8% in the
presence of SCH 23390 (z—5.2 4.3%). The FE1 of —5.2
4.3% in the group infused with SCH 23390 was significantly
different from the FE in the saline infused group, L9.5
5.2%. Urinary cAMP excretion was not different between the
vehicle and DA-l antagonist-infused rats (86.3 6.7 vs. 87.7
6.1 pmollml GFR).
Discussion
The fact that the remnant kidney in the rat develops chronic
renal insufficiency as reflected by a significant decrease in
glomerular filtration rate is well established [3]. The signifi-
cantly higher fractional excretion of phosphate exhibited by the
RK when compared to sham control rats is in agreement with
findings by previous investigators [6, 7]. It is interesting, as
previously reported, that this adaptive phosphaturia occurs
even in the absence of parathyroid glands. This observation was
also confirmed in our study, since rats were acutely thyropara-
thyroidectomized (TPTX).
Thus, factors other than those mediated by PTH contribute to
the enhanced fractional excretion of phosphate exhibited by
this model of early chronic renal insufficiency. We hypothesize
that alterations in catecholamines by the RK as evidenced by a
decreased tissue NE concentrations (suggesting a decreased
sympathetic tone to the proximal tubule); an increased intra-
renal DA synthesis per residual nephron is associated with the
enhanced fractional excretion of phosphate of the RK.
There is considerable evidence to support a role for the renal
nerves and catecholamines in the renal handling of phosphate.
The sympathetic innervation of the renal cortical tubules, as
well as the presence of a- and 3-adrenoreceptors in the proxi-
mal tubules is well documented [10—13]. Denervation has been
shown to decrease the maximum transport for phosphate in the
rat, to enhance the phosphaturic response to PTH, to restore
the phosphaturic response to PTH during short-term phosphate
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Fig. 1. Tissue norepinephrine (NE) and dopamine (DA) concentrations
in the remnant kidney (RK), and in the sham control intact kidney. .
Mean values are plotted with standard error bars. *Significantly differ- .
ent from control, unpaired 1-test, P < 0.05.
deprivation, and to increase urinary DA excretion [14, 32—34].
On the other hand, stimulation of /3-adrenoreceptors decreases
the maximum transport for phosphate, and stimulation of cs- and
/3-adrenoreceptors blunt the phosphaturic response to PTH[16,
17]. Further, DA infusion is phosphaturic in the dog and the rat
[22, 23]. DA has also been reported to increase phosphate
excretion, inhibiting sodium phosphate cotransport, and to
correlate with changes in dietary phosphate intake [23, 24, 35].
It is noteworthy that the compensatory growth that occurs in
the RK is well established to be due mainly to increases in
nephron size rather than in number and that the proximal tubule
is the nephron subsegment where the most dramatic enlarge-
ment occurs [1, 2]. Interestingly, the proximal tubules are also
the nephron site where phosphate reabsorption as well as
intrarenal DA synthesis take place [19]. Most models of com-
pensatory renal enlargement, particularly the ablative model
which we used, have been reported to result in strict renal
hypertrophy [2]. Since in the RK urinary DA is synthesized by
only 18.7% of the total nephron population, the urinary DA
excretion for sham control rats was expressed per an equivalent
nephron population. Further, using the nephron count by
Kaufman et al in an identical model of RK in the rat urinary DA
excretion was also expressed per nephron. Thus, urinary DA
excretion corrected per percentage of residual nephrons and per
nephron was significantly higher in rats with a RK than in sham
control rats with intact kidneys.
DA synthesized by the proximal tubules is distributed in a
larger volume in the hypertrophied nephrons of the RK when
compared to the nephrons of the sham kidney. Therefore, tissue
DA concentrations were not different between the two groups
when the whole kidney was homogenized and analyzed. None-
theless, this does not preclude the possibility that differences in
DA concentration may exist in the vicinity of the proximal
tubules, the nephron site of extraneuronal DA synthesis. Fur-
ther, tissue DA as well as intratubular DA, which has the
potential of being transported into the proximal tubular cells,
may be responsible for activation of DA receptors [36]. Thus,
equivalent concentrations of DA acting on an RK, with a
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Fig. 2. Absolute urinary dopamine (V DA) and phosphate ('P,l excre-
tions; calculated VDA excretion per nephron and fractional excretion
of phosphate (FE,,, %) in rats with a remnant kidney (RK, N = 10) and
in sham control rats with intact kidneys (N = 9). Mean values are
plotted with standard error bars. *Significantly different from control,
unpaired (-test, P < 0.05.
reduced number of hypertrophied proximal tubules, reflects an
enhanced DA content per residual nephron.
Norepinephrine content in the parotid, salivary glands, and in
homogenates of the heart have been reported to be decreased in
uremic rats. A decreased NE uptake was also shown in isolated
adrenergic storage vesicles from myocardial homogenates in
the same study [37]. In vitro studies performed by the same
group of investigators showed a significantly diminished ty-
rosine hydroxylase activity with advancing renal failure,
whereas the activity of monoamine oxidase was positively
correlated with the degree of renal failure. Thus, the synthesis
as well as the degradation of norepinephrine is suggested to be
altered in uremia. However, no measurements of renal tissue
norepinephrine levels in uremia have been reported, and no
study in the literature has proposed a link between the sym-
pathicopathy observed in uremia and the renal handling of
phosphate during early stages of chronic renal insufficiency by
the RK. The decreased tyrosine hydroxylase and increased
monoamine oxidase activities similar to that reported by Hen-
nemann, may not only explain the decreased tissue NE found in
the RK but may also indicate a decreased synthesis of DA by
neuronal tissue [37]. Tissue DA concentrations, which reflect
both neuronal and the renal synthesis of DA, were not different
between the RK and the sham control group. On the other
hand, urinary DA excretion per residual nephron was signifi-
cantly higher in rats with a RK than in the control sham rats
NE
RK Sham
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RK Sham
(N=10) (N=9)
140
120
100
80
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with intact kidneys. The finding of similar tissue DA levels
during chronic renal insufficiency by the RK, in the context of
a decreased neuronal DA release, further supports the notion
that urinary DA excretion by the RK probably represents
non-neuronal intrarenal DA synthesized by kidney proximal
tubular cells.
In additional experiments in rats with a RK, infusion of the
DA-l receptor antagonist (SCH 23390) significantly decreased
phosphate excretion when compared to saline infused control
rats. However, urinary cyclic AMP excretions were not differ-
ent between the two groups. Since infusion of SCH 23390
blunted but did not reverse the increased phosphate excretion
observed in the RK, it may be that alternative mechanisms may
also be mechanisms involved in the adaptive phosphaturia
exhibited by the RK.
It is important to note that the decreased sympathetic tone
and the increase in urinary DA excretion per residual nephron
by the RK were observed in acutely TPTX rats. Nonetheless,
we expect these findings to occur in the presence of parathyroid
glands and it is proposed that by increasing phosphate excretion
they may be playing a role in retarding the secondary hyper-
parathyroidism that accompanies chronic renal insufficiency
[38]. In this way, other factors in addition to those mediated by
PTH may be contributing to maintain phosphate balance during
early chronic renal insufficiency by the RK, and the metabolic
derangements that come with the development of secondary
hyperparathyroidism may be ameliorated.
In summary, our findings of decreased tissue norepinephrine
concentrations in the remnant kidney, but not tissue DA
content, and an increased urinary DA excretion per residual
nephron, strongly suggest that decreased renal tubular sympa-
thetic tone and increased DA synthesis per nephron are asso-
ciated with the enhanced fractional excretion of phosphate
exhibited by the RK model during early chronic renal insuffi-
ciency.
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Appendix
Weight of the right kidney and left kidney poles removed, total renal
mass removed, and calculated percentage of residual mass in rats with
a remnant kidney (RK)
Total
renal %
Right Left mass Residual
kidney kidney removed renal
g poles g g mass
Mean 1.02 0.27 1.29 37.7
SEM 0.02 0.01 0.03 0.8
Calculated percentage of residual nephrons and nephron population for
the remnant kidney (RK) of the present study. Calculations were based
on nephron counts performed by Kaufman eta! [311, in an identical RK
model compared to control intact kidneys.
RK-residual
renal mass
Number of nephrons
RK residual
% RK Intactkidney nephrons %
Kaufman eta! 28 10,650 75,076 14.1
Present study 37 14,073 75,076 18.7
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